A substrate is printed with front side and back side markings. The front side when viewed with reflected light includes: a first marking printed with a first gradient of two colors; a second marking printed with a second gradient of two colors; a first symbol printed with a third gradient of two colors; a second symbol printed with a fourth gradient of two colors; a third symbol printed with a fifth gradient of two colors; and a fourth symbol printed with a sixth gradient of two colors. The back side when viewed with reflected light includes: a third marking printed with the fourth gradient; a fourth marking printed with the third gradient; a fifth symbol printed with the second gradient; a sixth symbol printed with the first gradient; a seventh symbol printed with the sixth gradient; and an eighth symbol printed with the fifth gradient.

Examples are directed toward a substrate offset printed with front side markings on a first side and back side markings on a second side. The front side markings and the back side markings have dimensions in a micrometer range. The front side when viewed with reflected light comprises first portions of a plurality of characters. The back side when viewed with reflected light comprises second portions of the plurality of characters. The first portions and the second portions are printed, when viewed with transmitted light, to show the plurality of characters as whole characters having dimensions in the micrometer range.

Examples are directed toward anticounterfeit markings printed on a substrate. A method includes determining with a microprocessor running computer executable code non-transitorily stored on tangible computer readable media that: a first microprinting appears on a front side of the substrate as front side markings of first portions of a plurality of characters having dimensions in a micrometer range when viewed from the front side with reflected light, a second microprinting appears on a back side of the substrate as back side markings of second portions of the plurality of characters having dimensions in the micrometer range when viewed from the back side with reflected light, and the first microprinting and the second microprinting in combination appear as microprinting of whole characters of the plurality of characters when viewed with transmitted light.

A method controls the color in a printing press, which includes at least one printing station printing a respective color design. The method includes the procedures of determining a control factor to color model, printing a design on a web and acquiring color characteristics corresponding to the printed design on the web. The method further includes the procedures of determining the color quality of the printed color design and determining a required change to at least one control factor when a correction to the color characteristics of the printed design is required. The change to at least one control factor is determined by determining the at least one control factor with respective color related information, which results in a reference color characteristic, according to the control factor to color model. The method returns to the procedure of printing when a correction is not required.

Functionality is disclosed herein for producing articles with multiple color inks. A method of decorating, printing, or otherwise producing articles with multiple color inks includes continuously refilling an ink reservoir with multiple color inks in a sequential manner, and continuously applying the multiple color inks from the ink reservoir onto articles of manufacture to create decorated articles of manufacture.

A substrate is printed with front side and back side markings. The front side when viewed with reflected light includes: a first marking printed with a first gradient of two colors; a second marking printed with a second gradient of two colors; a first symbol printed with a third gradient of two colors; a second symbol printed with a fourth gradient of two colors; a third symbol printed with a fifth gradient of two colors; and a fourth symbol printed with a sixth gradient of two colors. The back side when viewed with reflected light includes: a third marking printed with the fourth gradient; a fourth marking printed with the third gradient; a fifth symbol printed with the second gradient; a sixth symbol printed with the first gradient; a seventh symbol printed with the sixth gradient; and an eighth symbol printed with the fifth gradient.

The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections.

This invention discloses an offset printing press for printing securities, which includes an offset printing unit, inspection camera unit, and sheet quality determination unit. The offset printing unit prints a ground tint pattern on a transported paper sheet. The inspection camera unit is arranged upstream of the offset printing unit in the direction in which the paper sheet is transported, and captures an image of the paper sheet. The sheet quality determination unit determines the quality of the paper sheet based on image data output from the inspection camera unit.

A substrate is printed with front side and back side markings in a first color ink. The front side when viewed with reflected light includes a first marking printed in a first saturation and a first symbol printed in the first saturation. The back side when viewed with reflected light includes: a second marking printed in a second saturation; a second symbol printed in the second saturation; a third marking printed in the first saturation; and a third symbol printed in the first saturation. The first marking, the second marking, and the third marking are printed to provide an interlocking pattern of low saturation color and high saturation color when viewed with transmitted light. The second symbol is visible, and the first symbol and the second symbol are not distinguishably visible, when viewed with transmitted light.

The invention provides for the use of pharmaceutical compositions comprising a thiazolide in the stimulation of the immune system in a subject in need thereof, thereby preventing and/or treating viral diseases, cancer and diseases caused by intracellular protozoan infections